A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations

Clinical trial NCT02299635 · TERMINATED

Trial details

NCT number: NCT02299635
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Neoplasms

Start date: 2015-02-03
Primary completion: 2016-01-14
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.